Sensorineural Hearing Loss
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 16 (7) , 322-325
Abstract
Background: Kawasaki disease (KD) is an acute systemic vasculitis of unknown etiology in which the main complication is coronary arteritis. Sensorineural hearing loss (SNHL) has also been described as a complication of this disorder. The objective of this study was to evaluate the prevalence of SNHL in patients with KD and to determine the possible causative abnormality, correlating the findings with the prevalence of cardiac complications, with the use of gammaglobulin, and with the results of laboratory tests. Methods: A clinical cohort of 40 patients with KD seen between 2005 and 2007 was evaluated by acoustic immittance measurement and brainstem-evoked response audiometry that were performed within the first 30 days of disease and 6 months after the first evaluation. Patients with hearing disability after this period underwent further testing through otoacoustic emissions analysis. All patients were treated with intravenous administration of immunoglobulin. Results: Ten (25%) of the 40 patients developed coronary aneurysm, and 22 (55%) disclosed hearing loss within the first 30 days, although this problem was noticed by the parents in only 3 children. In 12 (30%), the hearing loss persisted after 6 months. Ten (83.3%) of these 12 patients also showed thrombocytosis (platelets, >500,000), 8 (66%) had anemia (hemoglobin, 50 mm/hr) persisting more than 30 days. Conclusion: SNHL was more prevalent than coronary complications. A significant association was found between persistent SNHL, although often not initially noted, with a prolonged presence of thrombocytosis, anemia, and high erythrocyte sedimentation rate and the delayed use of intravenous administration of immunoglobulin after the first 10 days of illness.Keywords
This publication has 21 references indexed in Scilit:
- Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insightNature Reviews Microbiology, 2008
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart AssociationPediatrics, 2004
- Kawasaki syndromeThe Lancet, 2004
- The Effect of Kawasaki Disease on Cognition and BehaviorArchives of Pediatrics & Adolescent Medicine, 2000
- Mortality Among Persons with a History of Kawasaki Disease in Japan: Existence of Cardiac Sequelae Elevated the Mortality.Journal of Epidemiology, 2000
- Kawasaki SyndromeClinical Microbiology Reviews, 1998
- Facial palsy in Kawasaki syndromePediatric Neurology, 1997
- Long-term Consequences of Kawasaki DiseaseCirculation, 1996
- Sudden Death from Cardiac Causes in Children and Young AdultsNew England Journal of Medicine, 1996
- Ocular Manifestations of Kawasaki's Disease (Mucocutaneous Lymph Node Syndrome)American Journal of Ophthalmology, 1982